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Abstract
Nuclear migration is regulated by the LIS1 protein, which is the regulatory subunit of platelet activating factor (PAF) acetyl-
hydrolase, an enzyme complex that inactivates the lipid mediator PAF. Among other functions, PAF modulates cell
proliferation, but its effects upon mechanisms of the cell cycle are unknown. Here we show that PAF inhibited interkinetic
nuclear migration (IKNM) in retinal proliferating progenitors. The lipid did not, however, affect the velocity of nuclear
migration in cells that escaped IKNM blockade. The effect depended on the PAF receptor, Erk and p38 pathways and Chk1.
PAF induced no cell death, nor a reduction in nucleotide incorporation, which rules out an intra-S checkpoint.
Notwithstanding, the expected increase in cyclin B1 content during G2-phase was prevented in the proliferating cells. We
conclude that PAF blocks interkinetic nuclear migration in retinal progenitor cells through an unusual arrest of the cell cycle
at the transition from S to G2 phases. These data suggest the operation, in the developing retina, of a checkpoint that
monitors the transition from S to G2 phases of the cell cycle.
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Introduction
Progression of the cell cycle is precisely controlled by
checkpoints, the signaling networks that allow cells to monitor
successive events and ensure ordered cell proliferation and
genomic stability. These include a mechanism that prevents
transition from G1 to S phase while the DNA replication
machinery is not ready; an intra-S checkpoint, which monitors
the progress of DNA synthesis; surveillance over DNA damage
throughout the cell cycle; and a mechanism in M-phase, which
ensures that completion of cell division awaits proper alignment
and attachment of all chromosomes to the mitotic spindle
([1,2,3,4] for reviews). More importantly, checkpoints are not
only induced by occasional danger signals, but operate continu-
ously during the unperturbed cell cycle to guarantee smooth and
safe phase transitions [5,6].
Phases of the cell cycle in the nervous system, including both the
early neuroepithelium and ventricular zone of the mammalian
cerebral hemispheres, as well as the corresponding neuroblastic
layer (NBL) of the developing vertebrate retina, uniquely correlate
with the to-and-fro movement of the nuclei of proliferating cells,
known as interkinetic nuclear migration (IKNM). In each cell
division cycle, the nucleus of an elongated neural precursor that
enters G1 migrates from the apical end towards the basal side,
wherein DNA is duplicated. Upon completion of S phase, the
nucleus migrates back towards the lumen of the neural tube,
reaching the apical end of the cell, where mitosis takes place [7,8].
Current data support the hypothesis that IKNM is regulated by
unevenly distributed signals associated with the distinct phases of
the cell cycle [9]. An example is asymmetric Notch signaling,
which results from asymmetric mRNA stability in distinct phases
of the cell cycle, and controls neurogenic exit from the cell cycle by
imposing upon the basal to apical nuclear migration in retinal
progenitor cells [10,11].
Studies of the mechanisms that control the movement of the
nuclei proper have implicated microtubules [12,13], dynein and
centrosome proteins [14,15], SUN1/2 and Syne/Nesprin-1/2
complexes [16], as well as actomyosin-dependent forces based on
myosin II in nuclear transport along the IKNM path [17,18,19].
Recent work showed also that interkinetic nuclear movement
involves Ca
2+ transients dependent on functional gap junction
hemichannels [20,21]. The interplay among the involved
molecules and the mechanical events is, nonetheless, still
debatable.
Coordinated cell and nuclear movements are critical events of
embryonic development [22], and developmentally regulated
migration of newly-generated neurons within the mammalian
brain enrolls evolutionarily conserved mechanisms similar to the
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filamentous fungi. For example, striking similarities were reported
between the sequences of the proteins NUDF of Aspergillus nidulans
and LIS1 of mammals, as well as in their mechanisms of action
upon the dynein/dynactin components of the cytoskeleton
[23,24]. Indeed, mutations in NUDF block migration of nuclei
in growing hyphae [25], whereas mutations in LIS1 deregulate
IKNM [14,26].
LIS1 dimers constitute the regulatory subunit of the enzyme
platelet activating factor acetyl-hydrolase (PAFAH), which metab-
olizes and inactivates the pleiotropic lipid messenger platelet
activating factor (PAF, 1-O-alkyl-2-O-acetyl-sn-glycero-3-phospho-
rylcholine) [27,28]. Engagement of a G protein-coupled mem-
brane receptor for PAF (PAFR) leads to activation of phospho-
lipases A2, C and D, of the PI3-K and MAPK pathways, such as
Erk and p38, and inhibition of adenylyl cyclase in various cells and
tissues [29]. In addition, almost all signaling pathways induced by
PAFR are networked with tyrosine kinases [30].
Notwithstanding somewhat conflicting results, both the pres-
ence of PAF, as well as the hydrolytic activity of PAFAH affect
neuronal migration both in vivo and in vitro [31,32,33,34]. Based on
both the functional similarities between LIS1 and NUDF, and on
the known effects of PAF upon neuronal migration, we tested the
effects of PAF upon IKNM in the developing rat retina. We found
that a PAF-like lipid is produced within the developing retina, and
that PAF affects interkinetic nuclear migration. Unexpectedly,
however, the blockade of IKNM was not due to interfering with
nuclear movement, but rather unusually to the induction of a
Chk1-dependent cell cycle arrest at the S/G2 transition, in the
absence of either DNA synthesis blockade or damage.
Methods
All procedures complied with the Guidelines for the Care and
Use of Laboratory Animals, from the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research, and were
approved by the Committee for the Use of Experimental Animals
of the Institute of Biophysics.
Materials
PAF, C-PAF, lyso-PAF, PD98059 and LY294002 were from
Calbiochem; WEB2086 was a gift from Boehringer Ingelheim;
SB218078 was from Glaxo-Smith Kline; Forskolin, cheleritrin
chloride, SB239063, caffeine, 5-Bromo-2-deoxyuridine (BrdU),
DNAse (D4513), Hepes and glutamine from Sigma; Basal
Medium of Eagle, gentamicin from Gibco BRL; antibody against
BrdU (RPN 202) from Amersham Pharmacia, antibody against
phospho-histone H3 (9701) from Cell Signaling; protein A/G plus
agarose and antibodies against PAF receptor (sc-8744) and CHK1
were from Santa Cruz Biotechnology; and antibody against
phospho-histone H2AX Ser 139 (clone JBW301) from Upstate
Biotechnology. HRP-ABC kit was from Vector, fluorescent
secondary antibodies were from Molecular Probes and Jackson
ImmunoResearch.
Nuclear labeling and tissue culture
Lister hooded rats at 2 days postnatal were anaesthetized by
hypothermia and a solution of BrdU diluted in distilled water plus
0.007N of NaOH was injected intraperitoneally (60 mg/kg b.w.).
The animals were killed instantaneously by decapitation at 30 min
after the injection, their eyes were quickly removed and retinal
explants of about 1 mm61 mm, were prepared as described [35].
In each experiment, tissue fragments from all retinae were pooled
and mixed before explants corresponding to approximately 2
retina per data point were distributed among the experimental
groups. The explants were placed in 2 cm
2 plates containing
500 mL of BME with 2 mM glutamine and 10 mg/mL gentamicin.
The dissection procedure took less than 30 min. Culture plates
were kept at 37uC in the presence of various reagents, for 3 hours
except where noted. This culture period allows BrdU-labeled cells
that leave S phase, to proceed along G2 and M phases of the cell
cycle without re-entering G1 of the following cycle [36].
Histology
Tissue was fixed with 4% paraformaldehyde in sodium
phosphate buffer pH 7.4 (4% PF), and then oriented for transverse
sections under a dissecting microscope in an aluminum chamber
filled with OCT embedding medium. Transverse sections were cut
in a cryostat. Sections of the retina in situ were cut frozen from eyes
fixed with 4% PF, after infiltration of sucrose, and were mounted
on 200 mg/mL poly-L-lysine coated glass slides.
For immunolabeling of single cells, the explants were enzymat-
ically dissociated with 0.125% trypsin in a calcium- and
magnesium-free (CMF) saline for 10 min at 37uC and treated
with 0.2 mg/mL DNAse I for 5 min. The cells were allowed to
adhere in a slide covered with 200 mg/mL poli L-lysine for 30 min
at 37uC, and then fixed with 4%PF for 30 min.
Immunohistochemistry
Sections of retinal explants were incubated with 0.5% Triton X-
100 in phosphate buffered-saline (PBS) pH 7.4, for 15 min,
washed and incubated with 1% BSA in PBS for 30 min, followed
by primary antibody either for 1 hour at 37uC or overnight at
room temperature. Then, the sections were washed, incubated
with secondary antibodies, and stained with an HRP-ABC kit
using DAB as chromogen. In the cases where both antibodies to
phospho-histone H3 and BrdU were used, the slides were heated
in 10 mM citrate buffer at pH 6.0 in a microwave oven for antigen
retrieval [37], and developed with Alexa 555- and 488-conjugated
fluorescent secondary antibodies, respectively.
Immunocytochemistry for phospho-histone H2A.X
Following antigen retrieval, dissociated cells from either control
or treated explants were incubated with a mouse monoclonal
antibody against phospho-Histone H2A.X for 2 hours at room
temperature and developed with Alexa 555-conjugated anti-mouse
antibody. SYTOXH Green nucleic acid stain was used to visualize
retinal cell nuclei. Counts of c-H2AX foci were done at 630X
magnification for at least three hundred cells, under indirect
fluorescence in a Zeiss Axiophot microscope.
Tritiated thymidine assay
To measure DNA synthesis in vitro, retinal explants were
incubated with [
3H]-Thymidine, either during the 3-hour
experimental period or only during the last hour, washed and
homogenized following overnight incubation with 0.4 M NaOH.
Aliquots of the homogenates were precipitated with 100 volumes
of 10% trichloroacetic acid, and collected on GF/A Whatman
filters. Following additional washes, the filters were oven-dried at
110uC, and counted in a Packard model 1600TR liquid
scintillation analyzer.
Detection and counting of migrating nuclei
In the P2 rat retinae an S-phase zone corresponds to between
one-half and two-thirds of the transversal length of the
neuroblastic layer ([38] and unpublished results), and other studies
have shown that movements of the nuclei of neural progenitor cells
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phase [39]. Therefore, BrdU-labeled nuclei within the apical
(outer) third of the NBL were scored as migrating. Counts were
made of those, as well as of all labeled nuclei within rectangular
fields of 122 mM width across the whole extent of the NBL, at
1000X magnification under differential interference contrast in a
Zeiss Axiophot microscope. For each data point, three fields were
examined from each of three distinct explants. A nuclear migration
index was defined as the fraction of nuclei within the outer third of
the NBL, and a BrdU incorporation index was defined as the total
count of labeled nuclei within the counting field (Figure S1).
Velocity of nuclear movement
To estimate the velocity of nuclear movement, retinae from 2
day-old rats were dissected and explants were cut radially to allow
examination of nuclear migration along the full central-peripheral
gradient of retinal differentiation. In this particular experiment,
3 mg/mL BrdU were added after explantation for 30 minutes, then
the medium was changed and the explants were either maintained
in control medium or treated with 0.3 nM PAF for 0.5, 1, 2, or
3 hours.
Following the same procedures as above, the immunolabeled
explant sections were photographed at high resolution under
differential interference contrast, using a Zeiss Axiocam digital
camera on an Axiophot microscope, driven by Axiovision
software. In each photomontage of the whole section, 5 evenly
spaced lines were drawn perpendicular to the retinal surface, each
extending from the basal (inner) to the apical (outer) border of the
NBL, at one-sixth to five-sixths of the total eccentricity from the
central border of the section. Then, the positions of the 2 nuclei
located within 50 mm distance of the marked line that had moved
the furthest towards the apical border, were measured, averaged
and expressed as percentage of the total depth of the NBL (Figure
S2). The results were pooled within each of 10 evenly spaced
intervals, from the basal to the apical border of the NBL, of which
10% correspond to the innermost, while 100% correspond to the
outermost (mitotic) stratum. Data were collected for either control
or PAF-treated explants at 4 time points from 2 independent
experiments, each from 3–4 explants in duplicate. This procedure
allowed us to map a wavefront of IKNM from extensive sampling
at various intervals of time after BrdU labeling of the S-phase
nuclei.
Purification and identification of retinal lipids
Phospholipids from the neuroretina were extracted and partially
purified by bi-dimensional thin layer chromatography (bi-TLC),
following published procedures [40]. The phospholipids were
detected with iodine vapor, and the spot corresponding to a
commercial standard of PAF was scraped from the plate [41].
HPLC analysis was done using a Varian Chromatography Star
System connected to a pump (model Dynamax SD-200) with a loop
of 20 mL. The partially purified fraction, obtained from bi-TLC,
was separated in a reverse-phase column (LiChrosphereH 60 RP-
18, 12,5 cm64 mm I.D. 5 mm, Merck), and eluted in an isocratic
mobile phase of methanol:H2O (20:80 v/v) at a flow rate of
0,7 ml/min. Each sample was detected by UV absorbance at
205 nm. Commercial PAF, as well as other pure lipids were
similarly treated to serve as controls.
Purified Muller glial cell culture
Muller cell cultures were prepared from 2-day-old Lister
hooded rats, following a published procedure [42]. Briefly,
mechanically dissociated retinal cells were plated onto polyor-
nithine-coated 25 cm
2 polystyrene flasks, in DMEM/F12 medium
supplemented with 10% fetal bovine serum. The cultures were
incubated for 20–30 days until confluence, at the time of which
nearly all neurons had degenerated, leaving a highly purified
culture of Muller glial cells. The phospholipids were extracted as
described above, and compared with extracts from neural retina,
the vitread vascular layer, or the back of the eye containing the
sclera, choroid and immature pigment epithelium, mechanically
dissected from the eyes.
Platelet aggregation assay
The partially purified fraction obtained from bi-TLC was tested
also in a platelet aggregation assay, following published procedures
[43]. Rabbit blood platelets (3 to 4610
5 cells/mL) were treated
with 1 mM calcium and 5 mL of agonists, in Tyrode’s buffer. The
assay was analyzed in an aggregometer, with monitoring time of
5 min.
Western Blot
Total protein extracted from the retinae of 2 day-old rats were
separated by 10% SDS-PAGE, transferred onto nitrocellulose
membrane, and probed with a polyclonal goat anti-PAF receptor
antibody, followed by horseradish peroxidase-conjugated anti-goat
secondary antibody, and visualized using a chemiluminescent ECL
kit (GE Healthcare).
Measurement of Chk1 activity
Chk1 kinase assay was done in vitro using GST-Cdc25C200–256
as substrate as previously described [44]. Briefly, plasmid pGEX-
KG-GST-Cdc25C200–256 was introduced into cells of the trans-
formation competent BL21Star E. coli strain by electroporation.
GST-Cdc25C200–256 fusion protein was affinity-purified using a
glutathione sepharose 4B matrix (GS4B – Amersham Pharmacia)
following a batch method described by the manufacturers. After
incubation with 0.3 nM PAF for 45 min at 37uC, Chk1 was
immunoprecipitated from 1 mg of total retinal proteins by
incubation with 20 mg of a Chk1 specific antibody and 40 mlo f
A/G protein-agarose overnight at 4uC. For in vitro kinase assay, the
precipitate was incubated with incomplete kinase buffer (50 mM
Tris-HCl pH 7.4, 1 mM DTT, 10 mM MgCl2) in the presence of
10 mM ATP, 10 mCi c-ATP
32 and 5 ng of purified Cdc25C200–256
for 25 minutes at 30uC. The samples were separated by SDS-
PAGE and transferred to a nitrocellulose membrane, which was
exposed to a phosphor screen using a phosphor cassette overnight
at room temperature and developed by phosphorimager scanning
with a Storm 860 (GE). The same nitrocellulose membrane was
probed with an antibody to Chk1 as a control and results were
analyzed using Image J 1.42q software (NIH-USA).
Flow cytometry
Flow cytometric analyses were conducted on a FACScalibur
cytometer (BD Biosciences). Retinal explants, prepared as
described previously, were enzymatically dissociated with
0.125% trypsin in CMF solution for 10 min at 37uC and treated
with 0.2 mg/mL DNAse I for 5 min. Dissociated cells were fixed
with 4% PF for 30 min, washed, subject to antigen retrieval and
incubated with a rabbit polyclonal antibody against cyclin B1 at a
pre-titrated dilution for 2 h at 37uC and further developed with
DyLight 488-conjugated anti-rabbit. Then, a mouse monoclonal
antibody against BrdU was added for 1 hour at room tempera-
ture, and developed with DyLight 649-conjugated anti-mouse.
Data acquisition from at least 10,000 cells was carried out with
CellQuest software (BD Biosciences), and the Summit MoFlo
software (Cytomation) was used for further analyses. Cyclin B1
PAF-Induced Arrest of Retinal Cell Cycle
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population, as the difference between the median values of cells
labeled with the anti-cyclin B1 antibody and those stained with
secondary antibody alone, and expressed as percentage of control.
Statistical analysis
All quantitative data are expressed means 6 standard errors of
the mean. Statistical analysis was done using Prism v.5.0, by
analysis of variance followed by intergroup planned comparisons
with the Tuckey test. Statistical significance was set at p,0.05.
Results
Both PAF and its receptor are expressed in the
developing rat retina
Both uni- and bi-dimensional thin layer chromatograms of lipid
extracts of the neonatal rat retina showed a distinct spot coincident
with commercial PAF subject to the same conditions (Figures S3A,
S4A). This partially purified fraction, scraped and eluted from the
silica plate of bi-dimensional chromatograms, is here referred to as
PAF-like.
PAF-like from the neonatal rat retina induced platelet
aggregation, similar to commercial PAF. The PAFR antagonist
WEB 2086 prevented platelet aggregation induced by retinal PAF-
like, but not aggregation induced by thrombin (Fig. 1A). HPLC
showed a single peak of absorbance of PAF-like at the same elution
time as commercial PAF (Fig. 1B), whereas the HPLC peak of
phosphatidylethanolamine was distinct (Figure S3B). The com-
bined biological and biochemical results strongly suggest that
retinal PAF-like was either PAF itself or both a structurally- and
functionally-related lipid.
To test which retinal cells produce PAF-like, separate bi-
dimensional TLC preparations were made of: the posterior half of
the eye, containing the sclera, choroid and immature pigment
epithelium; the vascular network apposed to the vitreal margin of
the retina, which contains vascular endothelium, pericytes and
scattered macrophages [45]; purified Muller glial cell cultures, and
compared with extracts from neural retina. Among the extracts
examined with the current technique, only those from Muller cells
showed a distinctive spot at the expected PAF-like location,
suggesting that this major glial cell type of the developing retina
produces high amounts of PAF. The Muller cell cultures
apparently produced even higher amounts of PAF than macro-
phages (Figure S4).
A single 55 kDa band, corresponding to the molecular mass of
PAFR was detected by Western Blots of protein extracts from
neonatal rat retina (Fig. 1C). In immunolabeled sections from the
retina in situ, PAFR was found in all retinal layers, including the
neuroblastic layer (Fig. 1D), and the pattern of labeling suggest
that most, if not all, retinal cells at this stage contain PAFR. In
contrast with the labeling consistent with the membrane form of
PAFR (Fig. 1D, arrowheads), we found no evidence of an
additional, previously described nuclear form of the PAF receptor
[46]. Relevant to the aims of the present study, in single cells
dissociated from the neonatal retina, immunolabeling for PAFR
was found both in non-proliferating cells, and in those expressing
the cell cycle antigen Ki67 (Figure S5), thus confirming that retinal
progenitors contain the PAF receptor.
PAF blocks interkinetic nuclear migration
To examine the effects of PAF upon IKNM (Fig. 2D),
proliferating cells in S phase were pulse-labeled with BrdU in vivo.
Starting at 45–60 min after injection, retinal explants were treated
with various concentrations of PAF for an additional 3 h, and a
nuclear migration index was calculated as described in Methods.
PAF reduced the fraction of outward migrating nuclei with the
maximum effect of approximately 50% at 0.3 nM (Fig. 2A–C, E).
The hydrolysis-resistant PAF analog C-PAF also reduced the
nuclear migration index by a maximum of approximately 45%
(Table S1).
PAF did not affect the total number of BrdU-labeled nuclei
within the counting fields (Fig. 2F), and, despite our searching for
apoptotic profiles in every section examined throughout the study,
we detected only occasional apoptotic profiles labeled with BrdU
in either control or experimental explants (data not shown), thus
ruling out that PAF induced programmed cell death in these
experiments.
Effect of PAF is receptor-dependent and involves
multiple signal transduction pathways
Both the PAFR antagonist WEB2086 (10 nM) and the inactive
receptor-binding metabolite lyso-PAF (1 nM-1 mM) (Fig. 3A)
prevented the effects of PAF. Accordingly, no effects of the lipid
mediator were detected upon IKNM in the retina of mice deficient
for PAFR, whereas both wild-type and heterozygous mice were
sensitive to blockade of IKNM by PAF (Fig. 3B).
Pre-treatment of retinal explants with either the p42/44 MAP
kinase (Erk) inhibitor PD 98059 (20 mM), or with the p38 MAP
kinase inhibitor SB 239063 (20 mM) prevented the effect of PAF
(Fig. 3C,D). Both the PI3-kinase inhibitor LY 294002 (20 mM),
and the adenylyl cyclase activator forskolin (10 mM), which
stimulates the production of cAMP, also appeared to have similar,
albeit not statistically significant effects (Table S1). In contrast, the
PKC inhibitor chelerythrine chloride (1 mM) had no effect
(Fig. 3E). Thus, several signaling pathways downstream of the
plasma membrane PAFR are involved in the effect of PAF upon
IKNM.
Nuclei of proliferating cells at the end of the S-phase
escape PAF-induced blockade
Close examination of the reduced fraction of BrdU-labeled
nuclei that reached the outer third of the NBL after treatment with
PAF, showed a heterochromatic pattern of nucleotide incorpora-
tion (Fig. 4). Labeling was mottled and often located at the nuclear
periphery (Fig. 4C), quite distinct from the more homogeneous
labeling of a large proportion of the nuclei that reached the apical
border of the NBL in control explants (Fig. 4B). Labeling was also
mottled in a few nuclear profiles found slightly displaced from the
compact group of BrdU-labeled nuclei soon after injection of the
nucleotide (Fig. 4A). This heterochromatic pattern of BrdU
labeling is consistent with its incorporation at the end of S phase
[47], followed by almost immediate outward migration. The data,
therefore, indicate that in our experimental condition, only nuclei
pre-labeled at the latest stages of the S phase escaped the action of
PAF.
PAF does not interfere with the velocity of nuclear
movement proper
We then plotted the progressive displacement of a wavefront of
migrating nuclei at various time points after pulse-labeling with
BrdU in vitro. This allowed an estimate of the average speed of
displacement of nuclei along the basal to apical extent of the NBL.
The procedure was designed so as to avoid bias imposed by the
centro-peripheral gradient of retinal differentiation, but we found
no systematic differences along the central-peripheral axis, which
corroborates the other data obtained from randomly distributed
explants.
PAF-Induced Arrest of Retinal Cell Cycle
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difference between the nuclear migration indexes of either exper-
imental or control explants (Fig. 4E). Nonetheless, the respective
migration wavefronts were similar at all time points (Fig. 4D). Thus,
once nuclei managed to exit the Sphasestratum, they moved towards
the apical border of the NBL with normal velocity, irrespective of
treatment with PAF. Again, the BrdU incorporation index showed no
difference between the two groups at any time point (Fig. 4F). These
data showthat the blockade of nuclearmigration shown inFig. 2 does
not amount to an inability of retinal progenitor nuclei to move.
Treatment with PAF does not block DNA synthesis nor
causes DNA damage
Since our initial hypothesis, that PAF would affect the
movement of nuclei down the path of IKNM, does not fit the
results above, we turned our attention to cell cycle checkpoints, the
induction of which might affect the associated IKNM. We first
tested whether PAF activated an intra-S checkpoint, which is
typically induced by disruption of DNA replication, for example,
by DNA damage [48]. The incorporation of nucleotides was
Figure 1. PAF and PAF receptor in the retina of developing rats. A: Washed rabbit platelets were treated with two independent samples of
retina-derived PAF-like. Positive controls were commercial PAF (10 nM) and thrombin (50 nM), WEB2086 was used at 1 mM, and silica scraped from
remote areas of the TLC plate was used as negative control. Note that the PAF receptor antagonist blocked platelet aggregation induced by retina-
derived PAF-like, but not by thrombin; B: PAF-like subject to reverse phase HPLC eluted as a single peak (continuous line), coincident with pure
commercial PAF (dotted line); C: Western blot of PAFR among a total protein extract from P2 rat retina shows a single band. D–F:
Immunohistochemical detection of PAF receptor in transverse sections of newborn rat eyes. A negative control without primary antibody is shown in
F. Arrows in D show labeling consistent with a membrane receptor in various retinal layers; Arrows in E, F show optic nerve axons. GCL = ganglion
cell layer; IPL = inner plexiform layer; INL = inner nuclear layer; NBL = neuroblastic layer. Scale bars in D=50 mm; E, F=100 mm.
doi:10.1371/journal.pone.0016058.g001
PAF-Induced Arrest of Retinal Cell Cycle
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e16058similar to untreated explants following either the most effective
concentration of 0.3 nM PAF or of 1 mM PAF, which does not
block nuclear migration (Fig. 5A–C), and irrespective of whether
tritiated thymidine was added at either the beginning or only
during the last 1 hour of PAF treatment.
Furthermore, there were no significant differences between the
2 groups in the percentages of cells containing clusters of c-H2AX
foci indicative of DNA damage [49] (Fig. 6). Thus, PAF did not
induce DNA damage nor prevented DNA synthesis and, therefore,
the blockade of IKNM does not correspond to the induction of a
typical intra-S checkpoint.
Migration-arrested nuclei do not progress to G2/M
transition
The 3-hour incubation would have allowed enough time for
nuclei to pass through G2 and enter mitosis [36]. We, thus,
immunostained retinal sections for phosphorylated Histone H3,
which labels retinal nuclei at late G2- and M-phases [38], and
scored labeled nuclei along the IKNM path. No ectopic p-H3
labeling was detected in either control or PAF-treated retinae
(Fig. 5D and inset). Interestingly, the number of p-H3 labeled
nuclei was significantly reduced within the outer third of the NBL,
suggesting that the impaired progression of proliferating cells along
G2, induced by PAF, was not accompanied by cell cycle arrest at
either the G2/M transition or during M-phase. We also did not
notice any signs of mitotic chromosome condensation in BrdU-
labeled nuclei outside of the apical margin of the retina.
PAF prevents the build-up of cyclin B1 in arrested cells
The data suggested an arrest at the S/G2 transition. We,
therefore, tested whether PAF impaired the robust increase in the
content of cyclin B1 expected during G2 phase. The results
Figure 2. PAF blocks interkinetic nuclear migration. A–C: Sections of retinal explants immediately after dissection (A), at 3 h of incubation
either in control medium (B), or with 0.3 nM PAF (C); D: A schematic diagram of interkinetic nuclear migration in the developing retina. Red elements
mark the period of the cell cycle examined in the current study. E: Nuclear migration index in explants treated for 3 h with PAF. Notice the partial
blockade of interkinetic nuclear migration in the range 10
210-10
28M. * = p,0.01 vs. control; F: BrdU incorporation index, showing a constant
number of labeled nuclei across the NBL, irrespective of treatment with PAF; Data are means 6 S.E.M., n=3 in duplicate. * = p,0.01; ** = p,0.001.
Abbreviations as in Fig. 1.
doi:10.1371/journal.pone.0016058.g002
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increasing their content of cyclin B1 (Fig. 7A, B). These data
corroborate the hypothesis that PAF blocked the interkinetic
nuclear migration by arresting the cell cycle at the S/G2
transition.
PAF-induced arrest at the S/G2 transition depends on
Chk1
The protein kinases ataxia teleangiectasia mutated (ATM),
ATM-and-Rad3-related (ATR), and checkpoint kinases 1 and 2
(Chk1/Chk2) are major components of the mechanisms that
oversee the control of DNA replication and genomic integrity [50].
The evidence of an arrest of retinal progenitor cells at the end of S-
phase prompted a preliminary test of the involvement of those
checkpoint components in the effect of PAF. Treatment with PAF
induced activation of Chk1, as assayed in vitro by the phosphor-
ylation of a peptide containing a known target serine (Fig. 7C).
We, therefore, tested the effect of a Chk1 inhibitor upon nuclear
migration. SB 218078 prevented the effect of PAF (Fig. 7D),
indicating that Chk1 activity is required for the induction of the S/
G2 cell cycle arrest. In contrast, caffeine, which inhibits the
upstream ATM/ATR kinases, had no effect (Table S1).
Discussion
The initial aim of this investigation was to test for an effect of
PAF upon interkinetic nuclear migration in retinal progenitor
cells. Indeed, PAF induced partial blockade of IKNM, via
engagement of its cognate receptor, and mediated by activation
Figure 3. PAF-induced blockade of nuclear migration is receptor-mediated and modulated by several signal transduction
pathways. P2 retinal explants, pre-labeled with BrdU, were treated with 0.3 nM PAF for 3 h in the presence of various PAF receptor (PAFR)
antagonists or signaling inhibitors. A: Both a PAFR-ligand inactive PAF metabolite (Lyso-PAF 10 nM, left) and a PAFR antagonist (WEB2086 10 nM,
right) prevented the effect of PAF; B: Deletion of PAFR abrogates the effect of PAF upon interkinetic nuclear migration; C–E: Antagonists of both Erk
(C) and p38 (D) MAP kinases prevented the effect of PAF, whereas an inhibitor of protein kinase C (E) had no effect. Data are means 6 S.E.M., n=4 in
duplicate. ** = p,0.001.
doi:10.1371/journal.pone.0016058.g003
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PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e16058Figure 4. Nuclei of proliferating cells at the end of the S-phase escape PAF-induced blockade, and PAF does not interfere with
nuclear movement proper. A–C: High magnification of immunolabeled sections of retinal explants immediately after dissection (A), at 3 h of
incubation either in control medium (B), or with 1 nM PAF (C). Arrows highlight the mottled, predominantly peripheral pattern of BrdU incorporation
in nuclei departing from the S-phase stratum (A), and in the reduced number of nuclei that reach the outer portions of the neuroblastic layer in PAF-
treated explant (C), when compared with control (B). This labeling pattern is typical of nucleotide incorporation at the end of S-phase. Scale
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and p38 protein kinases. These data appeared consistent with the
aforementioned modulation of cell and nuclear migration by both
LIS1 and by PAF agonists and antagonists, as well as with
structural evidence for overlapping domains of interaction of LIS1
with both the catalytic subunits of PAFAH and the molecular
motor dynein [51].
Unexpectedly, however, mapping of the wavefront of migrating
nuclei in the current experiments failed to show any evidence that
the blockade of IKNM reflected impaired nuclear movement. This
and the absence of ectopic mitoses also diverge from a previous
study of the ventricular zone of the cerebral cortex [26], where it
was suggested that the nuclei of LIS1 deficient cells moved slowly
through G2 phase and therefore entered mitosis before reaching
the apical end of the proliferating neuroblasts. The lack of an effect
of PAF upon nuclear movement is in sharp contrast with the
blockade of nuclear movement induced by inhibition of the CK2
enzyme, which was clearly shown with the same methods
employed in the current study [13]. The present data, therefore,
suggest that the effect of the lipid mediator upon IKNM in retinal
progenitors is not related to the extensively studied roles of the
regulatory subunit of PAFAH upon microtubule dynamics and
molecular motor functions [52,53,54].
Indeed, the most significant result of our study was the unusual
evidence for an S/G2 cell cycle arrest provided by a PAF-induced,
Chk1-mediated mechanism. A DNA damage-induced intra-S
checkpoint [48] was ruled out by both the lack of reduced
nucleotide incorporation into DNA, as well as by the lack of
evidence of PAF-induced DNA strand breaks. In turn, an arrest at
the G2/M transition [55] was ruled out by the lack of H3 histone
phosphorylation in the arrested nuclei, which would be expected
to appear at late G2 just prior to chromosome condensation in
Figure 5. PAF induces a post-replication cell cycle arrest. A–C: Treatment with PAF does not block DNA replication. Tritiated thymidine was
equally incorporated in BrdU-labeled control and PAF-treated explants (A), irrespective of blockade of interkinetic nuclear migration (B and C are
controls from the same batch of explants used for the
3H-TDR measurements); ** = p,0.001. D: Arrested nuclei do not progress along the cell cycle.
Explants from the retina of animals pre-injected with BrdU were maintained either in control medium or treated with 0.3 nM PAF for various intervals,
and retinal sections were stained with antibodies to BrdU (green in the inset) and to phospho-histone H3 (red). Despite the blockade of nuclear
migration, no immunolabeling was detected among nuclei arrested within the inner 2/3 of the neuroblastic layer (inset), and all pH3-labeled nuclei
were located within the outer (apical) 1/3, albeit with a distinctive reduction in PAF-treated explants. Data are means 6 S.E.M., n=4 in duplicate;
** = p,0.001 vs. control at same time in vitro.
doi:10.1371/journal.pone.0016058.g005
bar =10 mm. D–F: Radially cut P2 retinal explants were pulse-labeled with BrdU in vitro and treated with 0.3 nM PAF for 0.5, 1, 2 or 3 hours. Then,
transverse sections immunolabeled for BrdU were used to map the location of the furthest migrating nuclei in 5 locations along the centro-peripheral
extent of the retina (central=1; peripheral=5). The mean average distances (wavefronts) travelled by the furthest migrating nuclei are shown in D,a s
percentage of the basal-to-apical extent of the neuroblastic layer, as a function of retinal eccentricity from the optic disk. Open circles = control, filled
triangles = PAF-treated. Note the coincident migration wavefronts, despite the distinct nuclear migration indexes (E,*=p ,0.01 vs. control).
Constant BrdU labeling index (F) is a control.
doi:10.1371/journal.pone.0016058.g004
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chromosome condensation in BrdU-labeled nuclei outside of the
apical margin of the retina. The cell cycle arrest induced by PAF
in retinal tissue is reminiscent of the induction by low-dose
ultraviolet irradiation of a postreplication checkpoint in yeast [57].
The interpretation that PAF-treated retinal progenitor cells
arrest at the S/G2 transition was further strengthened by the
combination of the blockade of IKNM at the basal side of the
proliferating cells with the abrogation of cyclin B1 build-up, which
would be expected to occur along the S/G2 transition and during
G2 [58,59]. Indeed, IKNM facilitates the assignment of events to
the S/G2 transition and early G2, as opposed to late G2 and the
G2/M transition [55,60,61]. It would be interesting to investigate
analogous events in non-neural tissue that also show IKNM, such
as the pseudostratified epithelium of the developing liver bud [62].
PAF reportedly induces proliferation of various cells types ([29]
for review), and the lipid activated both Erk and p38MAPK, and
stimulated proliferation in an epidermal cell line transduced with
PAFR [63]. In contrast, PAF inhibited proliferation and promoted
differentiation of various colon carcinoma cell lines, in parallel
with the activation of Erk, p38 and Jun N-terminal kinases [64].
The cell cycle inhibitory effect of PAF in the developing retina is
in line with the data in colon carcinoma cells, and required the
PAF receptor, as well as the activities of both the Erk and p38
MAP kinases. Differing cell cycle responses to PAF may be due to
cell type-specific conditions, such as the availability of trans-
interacting partners, as suggested for transduced epidermal cells
[63]. Notwithstanding, it is not clear how PAF can either stimulate
or inhibit the cell cycle while activating similar sets of signal
transduction pathways.
In retinal tissue, PAF activated Chk1, and a selective inhibitor of
Chk1 abrogated the lipid-induced blockade of IKNM. However,
the ATM/ATR inhibitor caffeine had no detectable effect. These
results suggest that the pathway of activation of Chk1 in the
induction of the S/G2 arrest differs from those induced by
irradiation [50]. Established models place p38 and Chk1/Chk2 at
non-overlapping arms of the DNA damage response [65], and
albeit p38 can phosphorylate Chk1, the former enzyme was ruled
out as a significant player in a mitotic phosphorylation of the latter
[66]. In turn, data were reported both that Erk is required for
Chk1 phosphorylation and G2-M arrest induced by a microtubule
disrupting agent in a colon cancer cell line [67], and that despite a
requirement of the MEK/Erk pathway for an intrinsic cell cycle
checkpoint that operates irrespective of DNA damage in Drosophila,
the mechanism may function either together or in parallel with
Chk1-dependent pathways [68]. We cannot, therefore, distinguish
between either parallel or sequential involvement of Erk, p38 and
Chk1 in the cell cycle arrest induced by PAF upon the retinal
progenitor cells. In addition, since our measurement of phosphor-
ylation of a substrate peptide revealed only the activity of Chk1,
further investigation is needed to define among the various
downstream targets of this enzyme [69], those relevant for
signaling originated from PAF receptors.
The concentration dependency of PAF, corresponding to an
inverted bell shaped curve (Fig. 2E), is typical of responses to this
mediator [70,71,72], similar to other lipids [73], although it is unclear
what are the relative contributions of mechanisms such as allosteric
m o d u l a t i o n[ 7 4 ] ,t h ep r e s e n c eo fm o r et h a no n ev a r i e t yo fr e c e p t o r
with distinct affinities [75], or other unknown mechanisms
[76,77,78]. Levels of PAF in 10 day-old postnatal rat retina in vivo
have been estimated at about 15 pg/mg of protein, undergoing a 3–4
increase upon hyperoxia [79], whereas in 3-day posthatch chick
retina, the best estimates amounted to roughly 1 ng/mg protein,
undergoing a 5–6 fold increase following stimulation with acetylcho-
line, dopamine or a calcium ionofore [80]. It is, however, difficult to
estimate the levels of extracellular PAF, because PAF-producing cells
release only part of the lipid produced [80]. Nonetheless, the effective
concentrations of PAF upon the retina in the present study are
consistent with both the physiological concentration of PAF in other
bodily fluids (within the 10
212-10
28 M range), and with the affinity of
the PAF receptor for its ligand (Kd=0.6 nM) [81,82].
Our data suggest the operation in retinal neuroblasts of a novel,
PAF-sensitive postreplication checkpoint that allows for cell cycle
arrest at the completion of DNA synthesis prior to the departure of
migrating nuclei at the outset of G2 phase. This concurs with the
regulation of the neural cell cycle by molecules traditionally
associated with immune responses [83,84,85], which may be
released by glial cells during neural development and, possibly,
Figure 6. Lack of significant DNA damage induced by PAF. A–B: Photomicrographs of the nuclei of cells dissociated from retinal explants
either untreated (A) or incubated with 0.3 nM PAF (B), double-labeled with the DNA marker SYTOX green, and with a monoclonal antibody to p-H2AX
developed with a red fluorochrome-labeled secondary antibody. C: Frequency of cells showing foci of p-H2AX in cells from either untreated or PAF-
treated retinal explants. Data are means 6 S.E.M., pooled from 4 independent experiments.
doi:10.1371/journal.pone.0016058.g006
PAF-Induced Arrest of Retinal Cell Cycle
PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e16058also in the context of the proliferation of adult neural progenitors
and stem cells. Indeed, our study showed that Muller cell cultures
contain an unexpectedly large amount of PAF. The relevance of
the latter data for the normal cell cycle is not yet clear, due to the
difficulty in extrapolating the findings in Muller cell cultures to the
developing retina in situ. Nonetheless, the Muller glia, which are
abundant at postnatal day 2, together with other cell types, such as
macrophages and microglia of the rat retina [45,86], may provide
PAF to receptor-bearing cells throughout the neuroblastic layer.
The production of PAF fluctuates during the cell cycle in yeast,
with the lowest content in S phase, related to the availability of
precursor and the activity of its synthesizing enzyme [87]. In turn,
a specific population of neurons, the horizontal cells of the chick
retina, lingers for approximately two days arrested at the G2 phase
of the cell cycle following the last round of DNA replication, before
they are released to progress through the M-phase of the
neurogenic division [88]. Both these data are consistent with the
suggested PAF-induced postreplication checkpoint. The functional
consequences of this effect of PAF remain to be examined in detail
in both the nervous system and other cell types.
Admittedly, the lack of an effect of the PAF antagonist upon basal
IKNM, as well as the similar rates of IKNM in wild-type and PAF
receptor-null mouse retinae, callinto question physiological correlates
of the PAF-induced blockade of IKNM. Nonetheless, given the
variety of lipids active upon the retina [89,90,91], functions of PAF
may be compensated by other lipid mediators in PAFR-null mice.
Indeed, compensatory mechanisms have been shown in single gene
knockout mice, whose lack of an expected phenotype apparently
challengedotherwisedemonstratedcompellingevidenceforfunctions
of the cognate proteins (e.g. [92,93]). Redundancy in the regulation of
an event as crucial as IKNM for neural development would be
expected, similar to what has been shown for various major
components of cell cycle control [93]. Thus, further studies are
warranted to effectively assess the role of PAF in normal retinal
development. Alternatively, the lipid induced cell cycle arrest during
retinal progenitor cell proliferation may be akin to the postulated
immune responses to danger signals [94]. In this regard, possible links
between the PAF-induced cell cycle arrest and oxidative stress
associated with diseases such as retinopathy of prematurity, diabetic
retinopathy and ischemic retinopathy [79,95] deserve investigation.
Figure 7. PAF blocks cyclin B1 increase during G2 phase, and PAF-induced cell cycle arrest depends on Chk1. A, B: Analysis of cyclin
B1 content in BrdU-labeled cells. A: Cytofluorograms gated on BrdU-labeled cells dissociated from either control or PAF-treated retinal explants
shows displacement of PAF-treated cells towards lower levels of cyclin B1; BKG = controls without primary cyclin B1 antibody; B: Mean and S.E.M. of
the median cyclin B1 fluorescent intensity in BrdU-labeled cells, averaged among 4 independent experiments. Data were normalized to the respective
controls in each experiment; * = p,0.01. C: Treatment of retinal explants with 0.3 nM PAF for 3 h induces an increase in the activity of Chk1, as
shown by increased phosphorylation of a target cdc25C peptide (n=2 with identical results) D: SB218078, a Chk1 inhibitor, blocks the effect of PAF
(Data are means 6 S.E.M., from n=5 independent experiments in duplicate); ** = p,0.001.
doi:10.1371/journal.pone.0016058.g007
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Figure S1 Analysis of interkinetic nuclear migration.
The top sequence illustrates the procedure for labeling prolifer-
ating cells with intraperitoneal injections of BrdU in vivo, retinal
dissection and explantation, incubation, sectioning and immuno-
histochemistry. The lower panels illustrate the counting method. A
counting field is delimited by the basal to apical extent of the
neuroblastic layer. Counts are made of all labeled nuclei (nNBL)
and, separately, of the nuclei located within the apical third of the
counting field (nOUT1/3). The nuclear migration and BrdU
incorporation indexes are explained in the frames. The lower right
graph is a plot of the evolution of the nuclear migration index with
time along the 3 hours of a typical experiment.
(TIF)
Figure S2 Analysis of the wavefront of migrating nuclei.
In this particular experiment, the explants were prepared through
radial cuts (red interrupted lines at the lower left), and BrdU was
given after retinal explantation. Explants were collected at various
intervals following the beginning of incubation with PAF, together
with untreated controls. The photomicrograph shows one section
immunolabeled for BrdU, and the counting procedure, as done on
photomicrographs taken through a light microscope. At each of 5
evenly spaced locations in sections taken along the central (C) to
peripheral (P) extent of the retina, a white line was drawn through
the neuroblastic layer, and parallel black lines at 50 mm on each
side delimited the scoring field. Within either side of the scoring
field, the distance from the basal edge of the NBL to the furthest
migrating nucleus was measured. The average of the 2 values was
expressed as a percentage of the total length of the neuroblastic
layer (white line) to provide one datum for that particular location.
As described in methods, data were collected from the 4 time
points in 2 independent duplicate experiments, each from 3–4
explants per data point, to provide a time course of advance of the
furthest migrating nuclei, along the centro-peripheral axis of
retinal eccentricity.
(TIF)
Figure S3 Additional data on the identification of a PAF-
like lipid in the developing retina. A: Thin layer
chromatography of commercial PAF, and of lipids of the neonatal
retina, extracted in either ethanol (ETOH) or chloroform (CHCl3).
Corresponding spots of commercial PAF and retinal PAF-like
lipids are circled. B: Reverse phase HPLC of commercial PAF and
of retina-extracted phosphatydilethanolamine (PE), used as
controls of elution in HPLC experiments.
(TIF)
Figure S4 Bi-dimensional Thin Layer Chromatograms
of lipids extracted. A: From the neural retina of postnatal (P)
day 2 rat. B: From the vascular network apposed to the vitreal
margin of the retina of P2 rats, which contains vascular
endothelium, pericytes and scattered macrophages [45]. C: From
the posterior half of the eye of P2 rats, containing the sclera,
choroid and immature pigment epithelium. D: From the purified
Muller glial cell cultures. Abbreviations: LPC = lysophosphati-
dylcholine; PC = phosphatidylcholine; PE = phosphatidyletha-
nolamine; PI = phosphatidylinositol; PS = phosphatidylserine;
PAF = platelet activating factor
(TIF)
Figure S5 Neonatal rat retina was dissociated, and cells
plated on poly-L-lysine coated coverslips were immuno-
stained for Ki67 (green) and for PAF receptor (red), and
counterstained with DAPI (blue). The photomicrograph
taken with epifluorescence in an Axiophot microscope shows
several triple labeled profiles indicating the expression of PAF
receptor in proliferating retinal progenitor cells.
(TIF)
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